Where We Can Make a Difference
We're drawing on our core capabilities.
"Merck for Mothers" will focus on the two leading causes of maternal mortality (post-partum hemorrhage and
preeclampsia) as well as family planning, which is known to play an important role in reducing maternal mortality.
The three main approaches for the long-term initiative include:
Accelerating Access to Proven Solutions
Merck intends to improve the quality and supply of diagnostic, prevention and treatment interventions for post-partum hemorrhage and preeclampsia. In addition, we will strengthen medical education for skilled birth attendants, help develop sustainable models for healthcare delivery, and expand access to family planning.
Drawing on our history of discovering innovative, life-saving medicines and vaccines, Merck will collaborate with partners to develop game-changing maternal health technologies for widespread use in resource-poor settings. Merck will start with an assessment of more than 30 promising existing technologies in partnership with leading donors, nongovernmental organizations (NGOs) and researchers, with a goal of developing at least three innovations that address post-partum hemorrhage, preeclampsia and family planning.
Global Awareness and Advocacy
We will join leading maternal health experts to create greater public awareness of the need to reduce maternal deaths in an effort to improve global and national policy. As part of "Merck for Mothers", Merck is pleased to be among the first companies to join the UN Global Compact/UN Foundation's Private Sector Task Force for Every Woman Every Child.
The initiative will be guided with input from both an internal steering committee and an external advisory board. We will hold ourselves accountable for the initiative's programs and outcomes by ensuring that an independent organization monitors and evaluates our efforts.